VPIM
LGND icon

Vanguard Personalized Indexing Management’s Ligand Pharmaceuticals LGND Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$432K Buy
2,162
+771
+55% +$153K ﹤0.01% 1391
2025
Q4 		$263K Buy
1,391
+55
+4% +$10.6K ﹤0.01% 1587
2025
Q3 		$237K Buy
+1,336
New +$199K ﹤0.01% 1612

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Vanguard Personalized Indexing Management's LGND Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Ligand Pharmaceuticals (LGND) stake by 55% in Q1 2026, buying an estimated $153K and bringing the position to 2,162 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Vanguard Personalized Indexing Management first reported a position in LGND in Q3 2025 and has held it in 3 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Vanguard Personalized Indexing Management held 2,162 shares of Ligand Pharmaceuticals worth $432K as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 771 Ligand Pharmaceuticals shares in Q1 2026, an estimated $153K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1391 holding.
  • Vanguard Personalized Indexing Management first reported a position in Ligand Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.